NASDAQ:BLUE Shareholder Notice: Lawsuit Alleges Misleading Statements by Bluebird Bio Inc
An investor, who purchased shares of bluebird bio Inc (NASDAQ:BLUE), filed a lawsuit over alleged violations of Federal Securities Laws by bluebird bio Inc.
View full press release